Vallente, Archie D.

HRN: 27-90-36  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/01/2025
AMPICILLIN 500MG (VIAL)
12/01/2025
12/08/2025
IV
160mg
Q6hours
PCAP-C
Checking Final Appropriateness 
12/02/2025
CEFUROXIME 750MG (VIAL)
12/02/2025
12/09/2025
IV
145mg
Q8
Pcap C
Waiting Final Action 
12/02/2025
GENTAMICIN 40MG/ML, 2ML (AMP)
12/02/2025
12/09/2025
IV
22mg
OD
Pcap C
Waiting Final Action 
12/04/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
12/04/2025
12/11/2025
IV
215mg
Every 6hours
Pneumonia
Checking Final Appropriateness 
12/07/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
12/07/2025
12/14/2025
IV
35mg
Every 6hours
Pneumonia
Checking Final Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: